Related Experiment Video
Updated: Jun 24, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Coupled SDE-ODE Modeling of Tumor-Immune Dynamics to Infer Biomarker Release
Pujan Shrestha1,2, Yijia Fan1,2, Jason T George3,4,5,6
1Department of Biomedical Engineering, Texas A&M University, College Station, 77843, TX, USA.
Bulletin of Mathematical Biology
|June 23, 2026
Summary
This study introduces a new mathematical model to understand how tumor-immune interactions influence biomarker signals like circulating tumor DNA (ctDNA). The framework helps infer cancer burden from noisy biomarker data, crucial for early-stage disease monitoring.
Area of Science:
- Oncology
- Immunology
- Mathematical Biology
Background:
- Tumor-immune interactions are critical for cancer progression and treatment outcomes.
- Monitoring early-stage or residual cancer relies on noisy biomarkers like circulating tumor DNA (ctDNA).
- Current methods struggle to accurately infer tumor burden from low-concentration biomarker signals.
Purpose of the Study:
- To develop a robust mathematical framework linking tumor-immune dynamics to biomarker release.
- To provide a mechanistically interpretable and mathematically tractable method for inferring tumor burden from noisy biomarker data.
- To analyze how tumor heterogeneity, immune pressure, and noise structure affect biomarker detectability.
Main Methods:
- Developed a coupled deterministic-stochastic framework integrating a Lotka-Volterra predator-prey model for tumor-immune dynamics.
- Modeled biomarker production using stochastic differential equations with both square-root and multiplicative noise.
- Derived analytical expressions for biomarker trajectories and first-passage statistics, including mean detection times.
Main Results:
- Demonstrated how tumor heterogeneity, immune pressure, and noise characteristics jointly influence biomarker emergence and detectability.
- Showcased the framework's ability to infer tumor burden from noisy biomarker signals across various concentration regimes.
- Provided insights into the dynamics of biomarker release driven by immune-mediated apoptosis and necrosis.
Conclusions:
- The developed framework offers a foundation for improved tumor burden inference from noisy biomarker signals.
- Understanding the interplay of tumor biology, immune response, and stochasticity is key for accurate cancer monitoring.
- This approach enhances the interpretability and tractability of biomarker-based cancer detection and management.

